Loading...

Joway Health Industries Group

OTCPK:GTVI
Snowflake Description

Mediocre balance sheet and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
GTVI
OTCPK
$802K
Market Cap
  1. Home
  2. US
  3. Consumer Durables
Company description

Joway Health Industries Group Inc., through its subsidiaries, manufactures, distributes, and sells tourmaline-related healthcare products. The last earnings update was 45 days ago. More info.


Add to Portfolio Compare Print
GTVI Share Price and Events
7 Day Returns
0%
OTCPK:GTVI
-1%
US Consumer Durables
-3.9%
US Market
1 Year Returns
-
OTCPK:GTVI
-2.2%
US Consumer Durables
1.4%
US Market
GTVI Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Joway Health Industries Group (GTVI) 0% -11.1% - - -20% -33.3%
US Consumer Durables -1% -0.3% 2.6% -2.2% 38.6% 29.9%
US Market -3.9% -3.6% 1.8% 1.4% 35.8% 40.8%
1 Year Return vs Industry and Market
  • No trading data on GTVI.
  • No trading data on GTVI.
Price Volatility
GTVI
Industry
5yr Volatility vs Market
Related Companies

Sorry, no analysis for Joway Health Industries Group's competitors could be found in our database.

Value

 Is Joway Health Industries Group undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Joway Health Industries Group. This is due to cash flow or dividend data being unavailable. The share price is $0.04.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Joway Health Industries Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Joway Health Industries Group's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:GTVI PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $-0.08
OTCPK:GTVI Share Price ** OTCPK (2019-05-01) in USD $0.04
United States of America Consumer Durables Industry PE Ratio Median Figure of 52 Publicly-Listed Consumer Durables Companies 14.53x
United States of America Market PE Ratio Median Figure of 3,087 Publicly-Listed Companies 17.79x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Joway Health Industries Group.

OTCPK:GTVI PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OTCPK:GTVI Share Price ÷ EPS (both in USD)

= 0.04 ÷ -0.08

-0.53x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Joway Health Industries Group is loss making, we can't compare its value to the US Consumer Durables industry average.
  • Joway Health Industries Group is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Joway Health Industries Group's expected growth come at a high price?
Raw Data
OTCPK:GTVI PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.53x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Consumer Durables Industry PEG Ratio Median Figure of 38 Publicly-Listed Consumer Durables Companies 1.13x
United States of America Market PEG Ratio Median Figure of 2,113 Publicly-Listed Companies 1.52x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Joway Health Industries Group, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Joway Health Industries Group's assets?
Raw Data
OTCPK:GTVI PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $0.21
OTCPK:GTVI Share Price * OTCPK (2019-05-01) in USD $0.04
United States of America Consumer Durables Industry PB Ratio Median Figure of 69 Publicly-Listed Consumer Durables Companies 1.3x
United States of America Market PB Ratio Median Figure of 5,195 Publicly-Listed Companies 1.83x
OTCPK:GTVI PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OTCPK:GTVI Share Price ÷ Book Value per Share (both in USD)

= 0.04 ÷ 0.21

0.19x

* Primary Listing of Joway Health Industries Group.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Joway Health Industries Group is good value based on assets compared to the US Consumer Durables industry average.
X
Value checks
We assess Joway Health Industries Group's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Consumer Durables industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Consumer Durables industry average (and greater than 0)? (1 check)
  5. Joway Health Industries Group has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Joway Health Industries Group expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Joway Health Industries Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
15.9%
Expected Consumer Durables industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Joway Health Industries Group expected to grow at an attractive rate?
  • Unable to compare Joway Health Industries Group's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Joway Health Industries Group's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare Joway Health Industries Group's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:GTVI Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Consumer Durables Industry Earnings Growth Rate Market Cap Weighted Average 15.9%
United States of America Consumer Durables Industry Revenue Growth Rate Market Cap Weighted Average 5.9%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:GTVI Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:GTVI Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 2 -1 -2
2018-09-30 2 -1 -1
2018-06-30 3 0 -1
2018-03-31 3 -1 -1
2017-12-31 3 0 -1
2017-09-30 4 1 0
2017-06-30 5 1 0
2017-03-31 4 1 0
2016-12-31 4 1 0
2016-09-30 3 0 -1
2016-06-30 3 0 -1
2016-03-31 3 0 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Joway Health Industries Group is high growth as no earnings estimate data is available.
  • Unable to determine if Joway Health Industries Group is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:GTVI Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Joway Health Industries Group Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:GTVI Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 -0.08
2018-09-30 -0.07
2018-06-30 -0.07
2018-03-31 -0.05
2017-12-31 -0.04
2017-09-30 0.01
2017-06-30 0.02
2017-03-31 0.00
2016-12-31 0.00
2016-09-30 -0.03
2016-06-30 -0.03
2016-03-31 -0.02

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Joway Health Industries Group will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of GTVI’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. Joway Health Industries Group's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Consumer Durables companies here
  3. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Joway Health Industries Group's filings and announcements here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Joway Health Industries Group's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Joway Health Industries Group has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Joway Health Industries Group performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Joway Health Industries Group's growth in the last year to its industry (Consumer Durables).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Joway Health Industries Group does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare Joway Health Industries Group's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Joway Health Industries Group's 1-year growth to the US Consumer Durables industry average as it is not currently profitable.
Earnings and Revenue History
Joway Health Industries Group's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Joway Health Industries Group Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:GTVI Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 1.67 -1.52 2.41
2018-09-30 2.17 -1.40 2.60
2018-06-30 2.51 -1.39 2.74
2018-03-31 2.97 -1.04 2.73
2017-12-31 3.30 -0.76 2.74
2017-09-30 4.37 0.15 2.64
2017-06-30 4.53 0.32 2.60
2017-03-31 4.19 0.07 2.67
2016-12-31 4.28 0.05 2.70
2016-09-30 3.43 -0.56 2.75
2016-06-30 3.40 -0.52 2.72
2016-03-31 3.47 -0.36 2.62
2015-12-31 3.33 -0.50 2.69
2015-09-30 3.12 -0.78 2.68
2015-06-30 2.75 -0.89 2.54
2015-03-31 2.20 -1.07 2.32
2014-12-31 1.70 -1.21 2.10
2014-09-30 1.51 -1.60 2.30
2014-06-30 1.41 -1.70 2.37
2014-03-31 1.40 -2.17 2.62
2013-12-31 1.39 -2.17 2.65
2013-09-30 1.26 -1.98 2.51
2013-06-30 1.17 -2.04 2.54
2013-03-31 1.29 -1.79 2.65
2012-12-31 1.90 -1.30 2.63
2012-09-30 2.29 -1.10 2.85
2012-06-30 2.90 -0.68 2.92

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Joway Health Industries Group has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Joway Health Industries Group has efficiently used its assets last year compared to the US Consumer Durables industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Joway Health Industries Group improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Joway Health Industries Group's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Consumer Durables industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Joway Health Industries Group has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Joway Health Industries Group's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Joway Health Industries Group's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Joway Health Industries Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Joway Health Industries Group has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Joway Health Industries Group's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Joway Health Industries Group Company Filings, last reported 4 months ago.

OTCPK:GTVI Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 4.25 0.64 0.12
2018-09-30 4.66 0.35 0.12
2018-06-30 5.16 0.26 0.30
2018-03-31 5.79 0.00 0.21
2017-12-31 6.04 0.13 0.52
2017-09-30 6.19 0.00 0.78
2017-06-30 6.37 0.00 0.80
2017-03-31 6.26 0.13 1.06
2016-12-31 6.39 0.00 0.92
2016-09-30 6.05 0.13 0.40
2016-06-30 6.20 0.13 0.39
2016-03-31 6.63 0.00 0.48
2015-12-31 6.79 0.13 0.37
2015-09-30 6.94 0.13 0.70
2015-06-30 7.33 0.04 0.48
2015-03-31 7.36 0.00 0.34
2014-12-31 7.68 0.04 0.54
2014-09-30 7.95 0.04 0.51
2014-06-30 8.13 0.05 0.54
2014-03-31 8.39 0.06 0.18
2013-12-31 8.94 0.07 0.48
2013-09-30 9.55 0.10 0.40
2013-06-30 9.78 0.10 0.61
2013-03-31 10.36 0.11 1.16
2012-12-31 10.79 0.12 1.79
2012-09-30 11.23 0.12 2.17
2012-06-30 11.59 0.21 2.60
  • Joway Health Industries Group's level of debt (15.2%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (0.8% vs 15.2% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Joway Health Industries Group has less than a year of cash runway based on current free cash flow.
  • Joway Health Industries Group has less than a year of cash runway if free cash flow continues to grow at historical rates of 57.4% each year.
X
Financial health checks
We assess Joway Health Industries Group's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Joway Health Industries Group has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Joway Health Industries Group's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Joway Health Industries Group dividends.
If you bought $2,000 of Joway Health Industries Group shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Joway Health Industries Group's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Joway Health Industries Group's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:GTVI Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Consumer Durables Industry Average Dividend Yield Market Cap Weighted Average of 21 Stocks 2.3%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1997 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.5%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Joway Health Industries Group has not reported any payouts.
  • Unable to verify if Joway Health Industries Group's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Joway Health Industries Group's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Joway Health Industries Group has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Joway Health Industries Group's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Joway Health Industries Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Joway Health Industries Group has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Joway Health Industries Group's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jinghe Zhang
COMPENSATION $32,655
AGE 53
TENURE AS CEO 8.7 years
CEO Bio

Mr. Jinghe Zhang is the Founder of Tianjin Joway Shengshi Group Co, Ltd. and has been its Chairman and Chief Executive Officer since 2007. Mr. Zhang has been Chief Executive Officer and President of Joway Health Industries Group Inc. since September 28, 2010. He serves as Chairman, Chief Executive Officer and General Manager of Joway Group. He has extensive experience in business management and product marketing. From January 2005 to May 2007, he was the Chairman and General Manager for Shenyang Joway Industrial Development Co., Ltd. From May 2003 to December 2004, he served as Chairman and General Manager of Shengyang Dazhou Healthcare Products Co., Ltd. He headed the marketing department of Tianjin Tianshi BiologicalEngineering Co., Ltd. from July 2000 to May 2003. From July 1988 to July 2000, he was employed as Sales Manager by Tianjin Hardware Procurement & Supply Station. He has been a Director of Joway Health Industries Group Inc. since September 28, 2010. Mr. Zhang received his bachelor degree in economics from Tianjin University of Finance and Economics in July 1988.

CEO Compensation
  • Jinghe's compensation has been consistent with company performance over the past year.
  • Jinghe's remuneration is lower than average for companies of similar size in United States of America.
Management Team

Jinghe Zhang

TITLE
Chairman of the Board
COMPENSATION
$33K
AGE
53
TENURE
8.7 yrs

Yuan Huang

TITLE
CFO, Secretary & Treasurer
AGE
47
TENURE
8.7 yrs
Board of Directors

Jinghe Zhang

TITLE
Chairman of the Board
COMPENSATION
$33K
AGE
53
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Joway Health Industries Group's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Joway Health Industries Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Best OTCPK Undervalued Stocks

Undervalued companies, such as Joway Health Industries Group and YaSheng Group, are those that trade at a price below their actual values. … GTVI's stock is currently trading at -89% under its true value of $0.46, at a price tag of $0.05, based on my discounted cash flow model. … MU's stock is currently floating at around -43% under its intrinsic value of $76.64, at the market price of $43.95, based on its expected future cash flows.

Simply Wall St -

OTCPK Top Cheap Stocks – Joway Health Industries Group And More

This is the case for Joway Health Industries Group and YaSheng Group. … GTVI's shares are currently floating at around -89% beneath its intrinsic value of $0.45, at a price tag of $0.05, according to my discounted cash flow model. … Additionally, HERB’s PE ratio stands at 0.3x relative to its food peer level of 20.7x, indicating that relative to its comparable company group, HERB can be bought at a cheaper price right now.

Simply Wall St -

Company Info

Description

Joway Health Industries Group Inc., through its subsidiaries, manufactures, distributes, and sells tourmaline-related healthcare products. The company operates in three segments: Healthcare Knit Goods, Daily Healthcare and Personal Care Products, and Wellness House and Activated Water Machine Products. It offers healthcare knit goods, including tourmaline treated mattresses, bed linen, underwear, pillows, and shirts; daily healthcare and personal care products, such as tourmaline-treated waist protectors, knee protectors, scarves, shampoo and soap products, toothpaste, and fish oil soft gel; and wellness house and activated water machine products comprising tourmaline wellness houses, foot sauna buckets, and tourmaline activated water machines and drinking mugs. The company markets and sells its products through a network of franchise stores. As of December 31, 2018, it had approximately 102 franchise stores. The company was formerly known as G2 Ventures, Inc. The company was founded in 2003 and is based in Tianjin, the People’s Republic of China. Joway Health Industries Group Inc. is a subsidiary of Crystal Globe Limited.

Details
Name: Joway Health Industries Group Inc.
GTVI
Exchange: OTCPK
Founded: 2003
$802,160
20,054,000
Website: http://www.jowayhealth.com
Address: Joway Health Industries Group Inc.
No. 19, Baowang Road,
Baodi Economic Development Zone,
Tianjin,
Tianjin Province, 301800,
China
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OTCPK GTVI Common Stock Pink Sheets LLC US USD 03. Oct 2010
Number of employees
Current staff
Staff numbers
66
Joway Health Industries Group employees.
Industry
Home Furnishings
Consumer Durables
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/16 02:16
End of day share price update: 2019/05/01 00:00
Last earnings filing: 2019/04/01
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.